News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
38,885 Results
Type
Article (2463)
Company Profile (39)
Press Release (36383)
Section
Business (14393)
Career Advice (79)
Deals (2110)
Drug Delivery (8)
Drug Development (4166)
Employer Resources (10)
FDA (445)
Job Trends (802)
News (20544)
Policy (1086)
Tag
2024 BioForest Digital (4)
2024 BioMidwest Digital (2)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (146)
Allergies (4)
Alliances (3517)
ALS (4)
Alzheimer's disease (46)
Antibody-drug conjugate (ADC) (14)
Approvals (447)
Artificial intelligence (9)
Autoimmune disease (2)
Automation (1)
Bankruptcy (11)
Best Places to Work (494)
BIOSECURE Act (2)
Biosimilars (12)
Biotechnology (29)
Bladder cancer (6)
Brain cancer (5)
Breast cancer (17)
Cancer (130)
Cardiovascular disease (4)
Career advice (66)
Career pathing (1)
CAR-T (14)
Cell therapy (42)
Cervical cancer (2)
Clinical research (3229)
Collaboration (88)
Compensation (44)
COVID-19 (181)
CRISPR (7)
C-suite (26)
Cystic fibrosis (2)
Data (104)
Denatured (3)
Depression (3)
Diabetes (9)
Diagnostics (466)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (13)
Drug pricing (7)
Duchenne muscular dystrophy (12)
Earnings (4277)
Editorial (3)
Employer branding (1)
Employer resources (8)
Events (6124)
Executive appointments (88)
FDA (487)
Featured Employer (3)
Funding (74)
Gene editing (14)
Gene therapy (17)
GLP-1 (60)
Government (151)
Healthcare (754)
Huntington's disease (3)
IgA nephropathy (3)
Immunology and inflammation (15)
Indications (2)
Infectious disease (186)
Inflammatory bowel disease (11)
Inflation Reduction Act (6)
Influenza (4)
Intellectual property (10)
Interviews (7)
IPO (998)
IRA (7)
Job creations (311)
Job search strategy (64)
Kidney cancer (4)
Labor market (3)
Layoffs (38)
Leadership (1)
Legal (220)
Liver cancer (5)
Lung cancer (15)
Lymphoma (4)
Management (4)
Manufacturing (18)
MASH (4)
Medical device (317)
Medtech (317)
Mergers & acquisitions (1172)
Metabolic disorders (32)
Multiple sclerosis (6)
Neurodegenerative disease (7)
Neuropsychiatric disorders (3)
Neuroscience (88)
NextGen: Class of 2025 (363)
Non-profit (162)
Northern California (333)
Now hiring (4)
Obesity (15)
Opinion (15)
Ovarian cancer (10)
Pain (8)
Pancreatic cancer (3)
Parkinson's disease (4)
Partnered (1)
Patents (19)
Patient recruitment (2)
Peanut (1)
People (5769)
Pharmaceutical (5)
Phase I (1384)
Phase II (1609)
Phase III (869)
Pipeline (71)
Podcasts (4)
Policy (11)
Postmarket research (33)
Preclinical (594)
Press Release (2)
Prostate cancer (3)
Psychedelics (2)
Radiopharmaceuticals (12)
Rare diseases (21)
Real estate (445)
Recruiting (5)
Regulatory (827)
Reports (6)
Research institute (143)
Resumes & cover letters (9)
Schizophrenia (10)
Series A (24)
Series B (5)
Service/supplier (2)
Sickle cell disease (1)
Southern California (338)
Special edition (1)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (492)
Stomach cancer (1)
Supply chain (4)
The Weekly (1)
United States (1635)
Vaccines (29)
Venture capitalists (7)
Webinars (2)
Weight loss (11)
Women's health (1)
Worklife (1)
Date
Today (27)
Last 7 days (64)
Last 30 days (229)
Last 365 days (2584)
2025 (627)
2024 (2626)
2023 (2880)
2022 (3781)
2021 (4098)
2020 (3519)
2019 (2156)
2018 (1624)
2017 (1819)
2016 (1661)
2015 (1858)
2014 (1402)
2013 (1220)
2012 (1451)
2011 (1375)
2010 (1210)
Location
Africa (44)
Alabama (1)
Arizona (14)
Asia (1884)
Australia (306)
California (775)
Canada (130)
China (39)
Colorado (19)
Connecticut (10)
Delaware (4)
Europe (3906)
Florida (44)
Georgia (6)
Idaho (3)
Illinois (14)
India (1)
Indiana (30)
Japan (7)
Kansas (12)
Maryland (25)
Massachusetts (283)
Michigan (8)
Minnesota (14)
Missouri (3)
Nebraska (1)
Nevada (2)
New Hampshire (2)
New Jersey (67)
New York (45)
North Carolina (89)
Northern California (333)
Ohio (25)
Oklahoma (2)
Oregon (4)
Pennsylvania (45)
Rhode Island (2)
South America (43)
South Carolina (1)
Southern California (338)
Tennessee (2)
Texas (66)
Utah (2)
Virginia (5)
Washington D.C. (1)
Washington State (44)
Wisconsin (6)
38,885 Results for "castle biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Castle Biosciences to Participate in Upcoming March 2025 Investor Conferences
February 26, 2025
·
1 min read
Press Releases
Ligand Leads $75 Million Royalty Financing in Castle Creek Biosciences
February 26, 2025
·
6 min read
Press Releases
Castle Biosciences Reports Fourth Quarter and Full-Year 2024 Results
February 27, 2025
·
19 min read
Press Releases
Castle Biosciences to Present New Data at EADO Supporting the Clinical Value of the DecisionDx®-Melanoma Test in Guiding Risk-Aligned Management of Patients with Melanoma
April 1, 2025
·
7 min read
Press Releases
Castle Biosciences’ DecisionDx®-SCC Data Earns Top Five Abstract at NCCN 2025, Shows Significantly Enhanced Risk Stratification Beyond Current Staging Within NCCN Risk Groups
March 31, 2025
·
8 min read
Press Releases
Castle Biosciences Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Results
January 13, 2025
·
9 min read
Press Releases
New Data to be Presented at the 2025 American Academy of Dermatology (AAD) Annual Meeting Further Strengthens Evidence Supporting the Clinical Value of Castle Biosciences’ Dermatology Portfolio
March 7, 2025
·
8 min read
Press Releases
Castle Biosciences to Participate in Upcoming Investor Conferences
October 28, 2024
·
1 min read
Business
Castle Biosciences Announces Updates to its Board of Directors
Castle Biosciences, Inc. announced that Rodney Cotton has been appointed to its board of directors, effective immediately, and will stand for election at Castle’s 2024 Annual Meeting of Stockholders, expected to be held in May 2024.
March 27, 2024
·
3 min read
Press Releases
Castle Biosciences to Release Fourth Quarter and Full-Year 2024 Financial Results and Host Conference Call on Thursday, Feb. 27, 2025
February 6, 2025
·
2 min read
1 of 3,889
Next
